Abstract
Conference Title: 2017 14th International Bhurban Conference on Applied Sciences and Technology (IBCAST) Conference Start Date: 2017, Jan. 10 Conference End Date: 2017, Jan. 14 Conference Location: Islamabad, Pakistan Background: Hepatocellular carcinoma (HCC) and Cholangiocarcinoma (CC) are primary liver cancers. HCC develops in hepatocytes while CC originates from bile duct epithelium. Due to the lack of early diagnosis, the incidence of HCC and CC are ever increasing and providing effective therapy to the patients suffering from these cancers have increasingly become difficult. The significance of clinical diagnosis of HCC by the detection of tumor markers has not been well documented. So far, none of the studies that indicate the presence of specific autoantibodies in CC, on the contrary to HCC, has been reported. The aim of our current study is to identify new immunological tumor markers for the diagnosis of HCC and CC.